To Cite:
Mirminachi
B, Mohammadi
Z, Merat
S, Neishabouri
A, Sharifi
A H, et al. Update on the Prevalence of Hepatitis C Virus Infection Among Iranian General Population: A Systematic Review and Meta-Analysis,
Hepat Mon.
2017
; 17(2):e42291.
doi: 10.5812/hepatmon.42291.
1.
Mohd Hanafiah K, Groeger J, Flaxman AD, Wiersma ST. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology. 2013; 57(4): 1333-42[DOI][PubMed]
2.
Perz JF, Armstrong GL, Farrington LA, Hutin YJ, Bell BP. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol. 2006; 45(4): 529-38[DOI][PubMed]
3.
Liakina V,
Hamid S,
Tanaka J,
Olafsson S,
Sharara AI,
Alavian SM,
et al.
Historical epidemiology of hepatitis C virus (HCV) in select countries - volume 3. J Viral Hepat. 2015; 22 Suppl 4: 4-20[DOI][PubMed]
4.
Moher D, Liberati A, Tetzlaff J, Altman DG, Prisma Group . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009; 151(4): 264-9[PubMed]
5.
Mohammadi Z,
Keshtkar A,
Eghtesad S,
Jeddian A,
Pourfatholah AA,
Maghsudlu M,
et al.
Epidemiological Profile of Hepatitis B Virus Infection in Iran in the Past 25 years; A Systematic Review and Meta-analysis of General Population Studies. Middle East J Dig Dis. 2016; 8(1): 5-18[DOI][PubMed]
6.
Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994; 50(4): 1088-101[PubMed]
7.
Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997; 315(7109): 629-34[PubMed]
8.
Salehi M, Sanei Moghaddam E, Bozorg Zadeh SR, Haghighi MR. Seroepidemiology of Hepatitis C in Sistan & Baloochestan province. . Zahedan J Res Medi Sci.3(3): 165-8
9.
Ansari-Moghaddam A, Ostovaneh MR, Sharifi Mood B, Sanei-Moghaddam E, Modabbernia A, Poustchi H. Seroprevalence of hepatitis B surface antigen and anti hepatitis C antibody in zahedan city, iran: a population-based study. Hepat Mon. 2012; 12(9)[DOI][PubMed]
10.
Jamali R,
Khonsari M,
Merat S,
Khoshnia M,
Jafari E,
Bahram Kalhori A,
et al.
Persistent alanine aminotransferase elevation among the general Iranian population: prevalence and causes. World J Gastroenterol. 2008; 14(18): 2867-71[PubMed]
11.
Merat S,
Rezvan H,
Nouraie M,
Jafari E,
Abolghasemi H,
Radmard AR,
et al.
Seroprevalence of hepatitis C virus: the first population-based study from Iran. Int J Infect Dis. 2010; 14 Suppl 3-6[DOI][PubMed]
12.
Poustchi H,
Esmaili S,
Mohamadkhani A,
Nikmahzar A,
Pourshams A,
Sepanlou SG,
et al.
The impact of illicit drug use on spontaneous hepatitis C clearance: experience from a large cohort population study. PLoS One. 2011; 6(8)[DOI][PubMed]
13.
Shakeri MT,
Nomani H,
Ghayour Mobarhan M,
Sima HR,
Gerayli S,
Shahbazi S,
et al.
The prevalence of hepatitis C virus in mashhad, iran: a population-based study. Hepat Mon. 2013; 13(3)[DOI][PubMed]
14.
Zamani F,
Sohrabi M,
Poustchi H,
Keyvani H,
Saeedian FS,
Ajdarkosh H,
et al.
Prevalence and risk factors of hepatitis C virus infection in amol city, north of iran: a population-based study (2008-2011). Hepat Mon. 2013; 13(12)[DOI][PubMed]
15.
Ghadir MR, Jafari E, Amiriani MT, Rezvan H, Amini S, Pourshams A. Hepatitis C in Golestan Province-Iran. . Govaresh. 2006; 11(3): 158-62
16.
Janbakhash A, Mansouri F, Vaziri S, Sayad B, Afsharian M, Abedanpor A. Seroepidemiology of herpes simplex virus type 2 (HSV2) in HIV infected patients in Kermanshah-Iran. Caspian J Intern Med. 2012; 3(4): 546-9[PubMed]
17.
The Prevalence of Hepatitis C Infection In General Population In Shiraz, Southern Iran. . The 13th Iranian congress of Microbiology.
18.
Fattahi MR, Safarpour A, Sepehrimanesh M, Hosseini Asl SM, Mohamaddoust F. The prevalence of hepatitis C virus infection and its related risk factors among the rural population of fars province, southern iran. Hepat Mon. 2015; 15(2)[DOI][PubMed]
19.
Moezzi M, Imani R, Karimi A, Pourheidar B. Hepatitis C Seroprevalence and Risk Factors in Adult Population of Chaharmahal and Bakhtiari Province of Iran in 2013. J Clin Diagn Res. 2015; 9(10)-7[DOI][PubMed]
20.
Alavian SM, Ahmadzad-Asl M, Bagheri Lankarani K, Shahbabaei MA, Bahrami Ahmadi A, Kabir A. Hepatitis C Infection in the General Population of Iran: A Systematic Review. . Hepat mon. 2009; 9(3): 211-23
21.
Akcam FZ, Uskun E, Avsar K, Songur Y. Hepatitis B virus and hepatitis C virus seroprevalence in rural areas of the southwestern region of Turkey. Int J Infect Dis. 2009; 13(2): 274-84[DOI][PubMed]
22.
Yildirim B,
Barut S,
Bulut Y,
Yenisehirli G,
Ozdemir M,
Cetin I,
et al.
Seroprevalence of hepatitis B and C viruses in the province of Tokat in the Black Sea region of Turkey: A population-based study. Turk J Gastroenterol. 2009; 20(1): 27-30[PubMed]
23.
Shemer-Avni Y,
el Astal Z,
Kemper O,
el Najjar KJ,
Yaari A,
Hanuka N,
et al.
Hepatitis C virus infection and genotypes in Southern Israel and the Gaza Strip. J Med Virol. 1998; 56(3): 230-3[PubMed]
24.
Bajubair MA, Elrub AA, Bather G. Hepatic viral infections in Yemen between 2000--2005. Saudi Med J. 2008; 29(6): 871-4[PubMed]
25.
Rezvan H, Abolghassemi H, Kafiabad SA. Transfusion-transmitted infections among multitransfused patients in Iran: a review. Transfus Med. 2007; 17(6): 425-33[DOI][PubMed]
26.
Alavian SM. We Need a New National Approach to Control Hepatitis C: It is Becoming too Late. . Hepat mon. 2008; 8(3): 1-3
27.
Alavian SM,
Hajarizadeh B,
Bagheri Lankarani K,
Sharafi H,
Ebrahimi Daryani N,
Merat S,
et al.
Recommendations for the Clinical Management of Hepatitis C in Iran: A Consensus-Based National Guideline. Hepat Mon. 2016; 16(8)[DOI][PubMed]
28.
Hesamizadeh K, Sharafi H, Rezaee-Zavareh MS, Behnava B, Alavian SM. Next Steps Toward Eradication of Hepatitis C in the Era of Direct Acting Antivirals. Hepat Mon. 2016; 16(4)[DOI][PubMed]
Readers' Comments